| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4273137 | The Journal of Sexual Medicine | 2007 | 9 Pages |
Abstract
Our data indicate that SHPRL, but not MHPRL, is a relevant determinant of HSD. Gynecomastia does not help in recognizing hyperprolactinemic subjects, while the use of psychotropic medications and HSD are possible markers of disease. In the case of MHPRL, repetitive venous sampling is strongly encouraged. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, Petrone L, Forti G, and Maggi M. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Giovanni MD, Edoardo MD, Alessandra D. MD, Francesco MD, Valdo Ricca, Giancarlo MD, Luisa Petrone, Gianni MD, Mario MD,